Zoetis Inc. (ZTS)
ZTSNYSEBiotechnology: Pharmaceutical Preparations
$82.85
+0.5300 (+0.64%) today
Regular session, Nov 10, 1:48 PM ET
- Market cap
- $33.66bn
- P/E
- 12.5
- EPS, last 4 quarters
- $6.63
- Dividend yield
- –
- Day range
- $80.43 to $82.90
- 52-week range
- $68.77 to $132.49
- Average volume
- 1.57m
- Previous close
- $82.32
Analysts
13 coveringHold4 buy, 9 hold, 0 sell
Targets a year out average $87.90, +6.1% from here
Earnings
next estimate $1.22Next report
Dec 2025
+5.7%
Mar 2026
-5.0%
Jun 2026
+1.6%
Sep 2026
+15.9%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $2.37bn | $2.26bn | $2.47bn | $2.39bn |
| Gross profit | $1.69bn | $1.62bn | $1.79bn | $1.69bn |
| Operating income | $835.00m | $800.00m | $922.00m | $863.00m |
| Net income | $624.00m | $601.00m | $691.00m | $591.00m |
Last four quarters: revenue $9.49bn, margin 26.4%, free cash flow $2.23bn
News
8 latest- ZTS Q3 Earnings Call Highlights Competitive Pressures and OutlookZacks · 1 day ago
- What Zoetis (ZTS) Said on Its Q3 Earnings CallMarketBeat · 1 day ago
- Zoetis Takes Over #296 Spot From ResMed BNK Invest · 4 days ago
- Zoetis: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 5 days ago
- Zoetis (ZTS) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Zoetis Inc. Reports Third Quarter 2026 Results and Updates Full Year 2026 GuidanceFintel · 5 days ago
- ZTS Q3 Earnings Top Estimates, 2026 Profit Outlook Improves, Stock UpZacks · 5 days ago
- Zoetis (ZTS) Reports Q3 Earnings: What Key Metrics Have to SayZacks · 5 days ago
The company
Zoetis is the world's leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit Zoetis.com.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- zoetis.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.